Loading stock data…
PRGO
$11.18-0.43 (-3.70%)
After Hours$11.36+0.18 (+1.61%)· Last close Jun 9
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Perrigo Company plc in the Healthcare sector is trading at $11.18. Wall Street consensus targets $16.50 (4 analysts), implying a +47.6% move over the next 12 months. The stock is currently near its 52-week low of $9.23, remaining 22.3% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +47.6% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$11.18
Potential Downside
0%
Whystock Fair Value$11.18
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper res...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
-
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Strong income play. Yield provides a meaningful total return floor.
5.19%
ROE
Average efficiency. Growth may require heavy reinvestment.
-72.74%
Volume
Today's trading volume
3.93M
Recent News
Perrigo Leadership Shakeup Puts Governance And Long Term Strategy In Focus
Perrigo (NYSE:PRGO) appointed Albert A. Manzone as Interim CEO and President after Patrick Lockwood-Taylor resigned. The Board stated that Lockwood-Taylor’s resignation followed conduct inconsistent with Perrigo’s Code of Conduct. The company has started a comprehensive search for a permanent CEO. Perrigo, trading at $11.61, is undergoing a significant leadership shift at a time when the stock has faced pressure over multiple time frames. The share price is down 16.4% year to date and down...
Perrigo CEO Ousted Over Personal Conduct
Perrigo Chief Executive Patrick Lockwood-Taylor has resigned after the board found his personal conduct had violated company code.
Why Is Perrigo (PRGO) Down 9% Since Last Earnings Report?
Perrigo (PRGO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Perrigo Q1 Earnings Surpass Estimates, Sales Miss, Both Fall Y/Y
PRGO beats Q1 EPS estimates despite lower sales. Weakness in cough and cold demand offsets gains in Women's Health and Infant Formula.
Assessing Perrigo (PRGO) Valuation After Weak Q1 Results And Lowered Guidance
Perrigo (PRGO) stock is in focus after the company reported first quarter sales of US$969.2 million and a net loss of US$398.6 million, which widened sharply from the prior year. See our latest analysis for Perrigo. The weak first quarter numbers and recent investigation headlines come after a difficult stretch for investors, with a 1 year total shareholder return of 50.36% and a 5 year total shareholder return of 67.42%. However, the recent 1 month share price return of 15.77% hints at short...